Cargando…

DMSO-tolerant ornithine decarboxylase (ODC) tandem assay optimised for high-throughput screening

Ornithine decarboxylase (ODC), the first rate-limiting enzyme in polyamine synthesis, has emerged as a therapeutic target for cancer and Alzheimer’s disease (AD). To inhibit ODC, α-difluoromethylornithine (DFMO), an irreversible ODC inhibitor, has been widely used. However, due to its poor pharmacok...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Mingu Gordon, Kim, Suyeon Yellena, Lee, C. Justin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9721421/
https://www.ncbi.nlm.nih.gov/pubmed/36451618
http://dx.doi.org/10.1080/14756366.2022.2150186

Ejemplares similares